Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 23, 2014Proteome ScienceOpen Access

Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches

View Full Paper
Ask AI
Bookmark
Share

Authors

IPIonela Daniela PopescuInstitutul National Victor BabesECElena CodriciCarol Davila University of Medicine and PharmacyLALucian AlbulescuInstitutul National Victor Babes

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Popescu et al. (2014) studied this question.

synapsesocial.com/papers/6a9039616e7e048e0989d191https://doi.org/10.1186/s12953-014-0047-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma2006 · 201 citations
  2. 2Mass profiling‐directed isolation and identification of a stage‐specific serologic protein biomarker of advanced prostate cancer2005 · 46 citations
  3. 3Genetic and Biologic Progression in Astrocytomas and Their Relation to Angiogenic Dysregulation2002 · 95 citations
  4. 4A SELDI mass spectrometry study of experimental autoimmune encephalomyelitis: sample preparation, reproducibility, and differential protein expression patterns2013 · 4 citations
  5. 5S100A9 has a protective role in inflammation‐induced skin carcinogenesis2014 · 29 citations